Ing C Olivetti SPA is now close to selling of its Olsy services subsidiary to Wang Laboratories Inc, according to UK press reports. The sale, first mooted last month (CI No 3,238) could be worth as much as $1bn, adding a huge $2.6bn of sales to Wang’s revenues. Olivetti would end up with a 19% stake in Wang, reports suggested.

White papers from our partners

ManageEngine

NIST’s guidance for a zero trust architecture

Hexaware-Technologies

Unlocking the Value of Cloud Migration with Automated Replatforming for a Leading Financial Firm

Darktrace

Email Security Threat Report 2020 4 key trends from spear phishing to credentials theft